Insider Buying Surge: CFO Krasner Andrew Jay Adds to Shareholdings On January 15, 2026 the Chief Financial Officer of Willis Towers Watson PLC, Andrew Jay Krasner, purchased 4,037.94 ordinary shares and 2,077.35 restricted‑share units, bringing his total holdings to 12,055.63 shares. The transaction, valued at zero dollars per share, reflects the typical vesting‑schedule mechanics of the company’s restricted‑share unit program rather than a cash‑backed purchase. Nonetheless, the move is significant in the context of a week marked by high social‑media buzz—757 % above average—and a bullish sentiment score of +88, suggesting that the market’s eyes are keenly watching insider actions.
What Does the Buy‑Signal Mean for Investors? Krasner’s recent activity is part of a broader pattern of incremental acquisitions. Over the past nine months he has executed 24 purchases of restricted units and ordinary shares, usually in the range of a few thousand shares each time. The most recent tranche coincides with a flat stock price of $329.40, just above the 52‑week low of $292.97 but well below the 52‑week high of $352.79. For investors, the CFO’s continued buying suggests confidence in the company’s strategic trajectory—especially its push into technology‑enabled insurance solutions and the forthcoming earnings announcement on February 3. In a sector where management alignment is a key valuation lever, such insider activity can serve as a subtle endorsement of the company’s growth prospects.
Willis Towers Watson’s Strategic Context The firm is actively expanding its data‑driven offerings, recently launching a Health Transparency Optimizer and a Databricks‑powered radar connector. These initiatives dovetail with the CFO’s stewardship of financial planning and risk management. The market’s neutral rating from Cantor Fitzgerald, coupled with a slight decline in the weekly change of –0.26 %, indicates that the stock is trading at a reasonable valuation of 15.39 P/E. The insider buying, therefore, may help tilt investor sentiment toward a more optimistic outlook, particularly if the company can deliver on its technology roadmap and capitalize on the rising demand for analytics in insurance.
Profile of CFO Andrew Jay Krasner Andrew Jay Krasner’s insider trading history is marked by disciplined, incremental purchases of both ordinary shares and restricted‑share units. Since late 2024, he has purchased roughly 30,000 shares in total, averaging about 1,250 shares per transaction. His trades have almost always been executed when the price is near the current market level, indicating a long‑term investment horizon rather than opportunistic short‑term speculation. Moreover, his transactions rarely involve large block trades or significant price swings, which is typical of a CFO focused on maintaining a stable equity stake in line with executive compensation plans.
Bottom Line For investors, the CFO’s recent buy adds a subtle layer of confidence amid a period of heightened social‑media attention. Coupled with Willis Towers Watson’s ongoing product expansion and a favorable earnings outlook, the insider activity reinforces the narrative that the company is poised for sustained growth. While no single transaction guarantees performance, the pattern of consistent, modest purchases by a senior executive suggests a belief in the long‑term value creation strategy of the firm.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-01-15 | Krasner Andrew Jay (Chief Financial Officer) | Buy | 11.28 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| N/A | Krasner Andrew Jay (Chief Financial Officer) | Holding | 12,055.63 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Krasner Andrew Jay (Chief Financial Officer) | Buy | 5.64 | N/A | Restricted Share Unit |
| 2026-01-15 | Krasner Andrew Jay (Chief Financial Officer) | Buy | 1.99 | N/A | Restricted Share Unit |
| 2026-01-15 | Pullum Anne (Co-Head of Corporate Dev.) | Buy | 5.43 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Pullum Anne (Co-Head of Corporate Dev.) | Buy | 6.67 | N/A | Restricted Share Unit |
| 2026-01-15 | Pullum Anne (Co-Head of Corporate Dev.) | Buy | 2.51 | N/A | Restricted Share Unit |
| 2026-01-15 | Kurpis Joseph Stephen (PAO and Controller) | Buy | 0.50 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Kurpis Joseph Stephen (PAO and Controller) | Buy | 1.06 | N/A | Restricted Share Unit |
| 2026-01-15 | Kurpis Joseph Stephen (PAO and Controller) | Buy | 1.23 | N/A | Restricted Share Unit |
| 2026-01-15 | Faber Alexis (Chief Operating Officer) | Buy | 4.70 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| N/A | Faber Alexis (Chief Operating Officer) | Holding | 1.00 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Faber Alexis (Chief Operating Officer) | Buy | 6.51 | N/A | Restricted Share Unit |
| 2026-01-15 | Faber Alexis (Chief Operating Officer) | Buy | 2.90 | N/A | Restricted Share Unit |
| 2026-01-15 | Furman Matthew (General Counsel) | Buy | 5.04 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Furman Matthew (General Counsel) | Buy | 8.96 | N/A | Restricted Share Unit |
| 2026-01-15 | Furman Matthew (General Counsel) | Buy | 7.13 | N/A | Restricted Share Unit |
| 2026-01-15 | Gebauer Julie Jarecke (Pres.-Health, Wealth & Career) | Buy | 8.89 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| N/A | Gebauer Julie Jarecke (Pres.-Health, Wealth & Career) | Holding | 534.00 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| N/A | Gebauer Julie Jarecke (Pres.-Health, Wealth & Career) | Holding | 534.00 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Gebauer Julie Jarecke (Pres.-Health, Wealth & Career) | Buy | 66.24 | N/A | Restricted Share Unit |
| 2026-01-15 | Gebauer Julie Jarecke (Pres.-Health, Wealth & Career) | Buy | 15.31 | N/A | Restricted Share Unit |
| 2026-01-15 | Hess Carl Aaron (Chief Executive Officer) | Buy | 41.05 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Hess Carl Aaron (Chief Executive Officer) | Buy | 26.70 | N/A | Restricted Share Unit |
| 2026-01-15 | Hess Carl Aaron (Chief Executive Officer) | Buy | 23.11 | N/A | Restricted Share Unit |
| 2026-01-15 | Banas Kristy D (Chief Human Resources Officer) | Buy | 4.33 | N/A | Ordinary Shares, nominal value $0.000304635 per share |
| 2026-01-15 | Banas Kristy D (Chief Human Resources Officer) | Buy | 3.18 | N/A | Restricted Share Unit |
| 2026-01-15 | Banas Kristy D (Chief Human Resources Officer) | Buy | 1.47 | N/A | Restricted Share Unit |
| 2026-01-15 | Clarke Lucy (President of Risk & Broking) | Buy | 30.39 | N/A | Ordinary Shares, nominal value $0.000304635 per share |




